CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 49 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -99.9% | 1,750 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,750 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 1,750 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 1,750 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -50.0% | 1,750 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | +33.3% | 1,750 | -30.0% | 0.00% | – |
| Q2 2021 | $6,000 | -14.3% | 2,500 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $5,961,621 | 2.46% |
| TOWERVIEW LLC | 400,000 | $728,000 | 0.48% |
| Orbimed Advisors | 6,943,654 | $12,637,450 | 0.25% |
| SAMLYN CAPITAL, LLC | 6,123,021 | $11,143,898 | 0.19% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $116,067 | 0.03% |
| Point72 Asset Management, L.P. | 5,964,510 | $10,855,408 | 0.03% |
| Masso Torrence Wealth Management Inc. | 10,000 | $18,200 | 0.01% |
| Hikari Power Ltd | 49,959 | $91 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 127,300 | $231,686 | 0.01% |
| Quinn Opportunity Partners LLC | 22,327 | $40,635 | 0.01% |